DK172578B1 - IgE-bindingsfaktorer fra kolostrum fremgangsmåder til fremstilling deraf, anvendelse af disse faktorer samt farmaceutisk pr - Google Patents

IgE-bindingsfaktorer fra kolostrum fremgangsmåder til fremstilling deraf, anvendelse af disse faktorer samt farmaceutisk pr Download PDF

Info

Publication number
DK172578B1
DK172578B1 DK198600372A DK37286A DK172578B1 DK 172578 B1 DK172578 B1 DK 172578B1 DK 198600372 A DK198600372 A DK 198600372A DK 37286 A DK37286 A DK 37286A DK 172578 B1 DK172578 B1 DK 172578B1
Authority
DK
Denmark
Prior art keywords
ige
bfs
colostrum
factors
igm
Prior art date
Application number
DK198600372A
Other languages
Danish (da)
English (en)
Other versions
DK37286A (da
DK37286D0 (da
Inventor
Guy Delespesse
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of DK37286D0 publication Critical patent/DK37286D0/da
Publication of DK37286A publication Critical patent/DK37286A/da
Application granted granted Critical
Publication of DK172578B1 publication Critical patent/DK172578B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/832—Milk; colostrum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/862—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgE or IgD
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK198600372A 1985-01-26 1986-01-24 IgE-bindingsfaktorer fra kolostrum fremgangsmåder til fremstilling deraf, anvendelse af disse faktorer samt farmaceutisk pr DK172578B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858502006A GB8502006D0 (en) 1985-01-26 1985-01-26 Polypeptide factors from colostrum
GB8502006 1985-01-26

Publications (3)

Publication Number Publication Date
DK37286D0 DK37286D0 (da) 1986-01-24
DK37286A DK37286A (da) 1986-07-27
DK172578B1 true DK172578B1 (da) 1999-02-01

Family

ID=10573467

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198600372A DK172578B1 (da) 1985-01-26 1986-01-24 IgE-bindingsfaktorer fra kolostrum fremgangsmåder til fremstilling deraf, anvendelse af disse faktorer samt farmaceutisk pr

Country Status (8)

Country Link
US (2) US4866037A (de)
EP (1) EP0190099B1 (de)
JP (1) JPH0723398B2 (de)
CA (1) CA1263937A (de)
DE (1) DE3688337T2 (de)
DK (1) DK172578B1 (de)
GB (1) GB8502006D0 (de)
IE (1) IE59582B1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5272255A (en) * 1985-01-26 1993-12-21 Ciba-Geigy Corporation Polypeptide factors from colostrum
US4946788A (en) * 1985-06-11 1990-08-07 Ciba-Geigy Corporation Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications
GB8514732D0 (en) * 1985-06-11 1985-07-10 Ciba Geigy Ag Purified immunoglobulin-related factor
FR2588476A1 (fr) * 1985-10-11 1987-04-17 Pasteur Institut Facteur inhibant la fixation des ige sur les mastocytes, procede d'obtention et applications
EP0338229B1 (de) * 1988-04-19 1993-06-16 Biotest Pharma Gmbh Präparat mit Antikörperaktivität und breitem Wirkungsspektrum, daraus bestehende oder diese enthaltende Mittel und deren Verwendung zur Behandlung von bakteriell oder toxin-bedingten Erkrankungen und zur Bekämpfung von Protozoen
US5565338A (en) * 1990-06-04 1996-10-15 La Jolla Institute For Allergy And Immunology Suppressor T-cell hybridoma and production of allergen specific glycosylation inhibiting factor
WO1993002696A1 (en) * 1991-08-07 1993-02-18 Medical Biology Institute T-cell membrane protein for b cell ig class switching
FI91166C (fi) * 1991-10-17 1994-05-25 Valio Biotuotteet Oy Ternimaitofraktio, menetelmä sen valmistamiseksi ja sen käyttö kasvualustojen täydennysaineena
NZ273865A (en) * 1993-09-20 1997-12-19 Anadis Ltd Obtaining high purity ig from antibody rich colostrum and compositions thereof
BR0318333A (pt) * 2003-07-07 2006-07-11 Luiz Fernando Mesquita processo de obtenção de complexo liofilizado a partir de segregado extraìdo da glándula de mamìferos, seu uso no tratamento de imunodeficiências e método de tratamento
JP2006096752A (ja) * 2004-08-31 2006-04-13 Ortho Corp 初乳又は初乳由来組成物、及び、初乳又は初乳由来組成物を用いた方法
WO2006029518A1 (en) * 2004-09-14 2006-03-23 Nexcell Biosciences Inc. Isolation of growth and differentiating factors from colostrum

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3553317A (en) * 1969-06-02 1971-01-05 Joseph B Michaelson Ig-a antibody from lacteal fluids
FR2520235A1 (fr) * 1982-01-27 1983-07-29 Bel Fromageries Procede de separation d'immunoglobulines a partir de colostrum
US4816563A (en) * 1983-11-25 1989-03-28 Amtron, Inc. Process for obtaining transfer factor from colostrum, transfer factor so obtained and use thereof
US4758511A (en) * 1984-03-16 1988-07-19 Dnax Research Institute Of Molecular And Cellular Biology, Inc. CDNA clones coding for polypeptides exhibiting IGE binding factor activity
JPS60255734A (ja) * 1984-05-30 1985-12-17 Nichirei:Kk クラス特異的Ｆｃεレセプタ−に対する単クロ−ン性抗体とそれを産生するハイブリド−マ
DE3432718C1 (de) * 1984-09-06 1986-05-22 Biotest Pharma GmbH, 6000 Frankfurt Verfahren zur Herstellung einer Loesung von Milch- und/oder Kolostralimmunglobulinen
US4946788A (en) * 1985-06-11 1990-08-07 Ciba-Geigy Corporation Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications

Also Published As

Publication number Publication date
GB8502006D0 (en) 1985-02-27
DK37286A (da) 1986-07-27
CA1263937A (en) 1989-12-19
IE59582B1 (en) 1994-03-09
EP0190099A2 (de) 1986-08-06
IE860212L (en) 1986-07-26
DE3688337T2 (de) 1993-10-07
JPS61210037A (ja) 1986-09-18
DK37286D0 (da) 1986-01-24
US4866037A (en) 1989-09-12
EP0190099B1 (de) 1993-04-28
EP0190099A3 (en) 1988-01-13
JPH0723398B2 (ja) 1995-03-15
US5371073A (en) 1994-12-06
DE3688337D1 (de) 1993-06-03

Similar Documents

Publication Publication Date Title
Mannick et al. Prolongation of allograft survival by an alpha globulin isolated from normal blood
JP2635444B2 (ja) 自己抗体の経口投与による自己免疫性疾患の治療
DK172578B1 (da) IgE-bindingsfaktorer fra kolostrum fremgangsmåder til fremstilling deraf, anvendelse af disse faktorer samt farmaceutisk pr
Baseler et al. Purification of haptoglobin and its effects on lymphocyte and alveolar macrophage responses
EP0932623A1 (de) Colostrinin und dessen verwendungen
AU657915B2 (en) Transfer factor and methods of use
JP4354812B2 (ja) 可溶性トール様受容体
JPH09509164A (ja) 免疫グロブリンａを用いた炎症を予防及び治療するための組成物並びに方法
JP2001508448A (ja) フェチュインと治療剤との複合体及び組合せ物
Malmström et al. Immunogenetic markers and immune response in patients with recurrent oral ulceration
WO1990011293A1 (en) Allergenic proteins from ragweed and uses therefor
AU613932B2 (en) Immunosuppressive polypeptides
Leung et al. Potentiation of human immunoglobulin E synthesis by plasma immunoglobulin E binding factors from patients with the hyperimmunoglobulin E syndrome.
US5272255A (en) Polypeptide factors from colostrum
MacDonald et al. Histamine-releasing factors and heterogeneity of IgE
Schirrmacher et al. Cytotoxic Immune Cells with Specificity for Defined Soluble Antigens: V. Interaction of Antibody with the Cytotoxic Effector Cells in Immune or Non-Immune Mouse Spleen Cells
JPH0453848B2 (de)
JPH10506877A (ja) ライグラス花粉アレルゲンのｔ細胞エピトープ
CA2078805C (en) Cytokine preparation
US6521263B1 (en) Immunomodulatory factors for immunosuppresant and antiallergic treatment
Dopfer et al. In vivo effects of interleukin 2 on lymphocyte subpopulations in a patient with a combined immunodeficiency
US6372219B1 (en) Parasite-derived anti-inflammatory immunomodulatory protein
JPH01501597A (ja) 血小板の活性化を抑制する新規なリンフオカイン、その単離法と精製法およびそれを含有する医薬
CA2021739A1 (en) Immunostimulating proteins, corresponding polyclonal and monoclonal antibodies, corresponding hybridomas for uses in therapy and diagnosis
CA2055593A1 (en) Respiratory burst suppression factor